May. 13 at 8:25 PM
$SPRO
So, no updates at all, in regard to the request for additional shares, and no indication other than the boilerplate language as to the path ahead for the organization post the PDUFA. Very annoyed with this Board for their lack of clarity in regard to the massive increase in share requests, especially in light of the fact that they have mothballed all the clinical trials other than Teb. I think we are looking at a payout here post approval, but because of the mixed messages being provided via their request for additional shares, they’re causing a great deal of angst for us to shareholders.
